Target intelligence / Profile preview

Guanine-Cytosine-rich DNA promoter motifs (GC-rich motifs)

Target
GC-rich motifs
Molecular classification
DNA regulatory element, Nucleic acid, Promoter sequence
01

Overview

Guanine-Cytosine (GC)-rich DNA promoter motifs are critical regulatory elements located within the proximal promoter regions of approximately 60-70% of mammalian genes, including many essential housekeeping genes and potent oncogenes [1]. These motifs, often referred to as GC boxes, typically serve as high-affinity binding sites for the Sp1 (Specificity Protein 1) family of transcription factors, which orchestrate the recruitment of the basal transcription machinery to initiate gene expression [2]. In various malignancies, the aberrant activation of genes controlled by GC-rich promoters—such as c-Myc, VEGF, and BCL2—drives tumor progression, angiogenesis, and resistance to apoptosis [2]. Therapeutic strategies targeting these motifs involve small-molecule ligands, such as Mithramycin A and its derivatives, which bind to the DNA minor groove to competitively inhibit transcription factor binding [3, 4]. While effective at downregulating pathogenic genes, the ubiquitous nature of GC-rich sequences across the genome presents significant challenges regarding off-target effects and systemic toxicity, necessitating the development of more selective analogs [4, 5]. Sources: [1] Suske G. Gene. 1999;238(2):291-300. [2] Vizcaíno C, et al. J Hematol Oncol. 2015;8:8. [3] Miller DM, et al. Cancer. 1987;60(11):2604-2611. [4] Albertini V, et al. Med Res Rev. 2010;30(2):310-341. [5] NIH PubChem Compound Summary for Mithramycin A.

Other names
GC boxesSp1-binding sitesG-rich promoter elementsCpG-rich promotersGC-rich regulatory elements
02

Mechanism of action

Small molecule ligands bind to the minor groove of GC-rich DNA sequences, physically displacing transcription factors such as Sp1 and preventing the assembly of the transcription initiation complex, thereby inhibiting the expression of downstream genes [3, 4].

03

Biological functions

Transcription regulationGene expression initiationTranscription factor bindingChromatin remodelingEpigenetic regulation
04

Disease associations

CancerViral infectionGenetic disordersInflammation
05

Safety considerations

Systemic toxicityHepatotoxicityThrombocytopeniaLack of sequence specificity leading to off-target gene suppressionNarrow therapeutic window
06

Interacting drugs

Mithramycin A (Plicamycin)

5 more in the full profile.

07

Biomarkers

Sp1 transcription factor expression levelsPromoter methylation statusmRNA levels of target oncogenes (e.g., c-Myc, VEGF, BCL2)G-quadruplex formation frequency

Beyond the preview

Go deeper on Guanine-Cytosine-rich DNA promoter motifs (GC-rich motifs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanine-Cytosine-rich DNA promoter motifs (GC-rich motifs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call